Ares Capital Corp
XBER:9A2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ares Capital Corp
XBER:9A2
|
US |
|
W
|
Weyerhaeuser Co
F:WHC
|
US |
|
Lufax Holding Ltd
NYSE:LU
|
CN |
|
F
|
Factset Research Systems Inc
DUS:FA1
|
US |
|
Industrias Penoles SAB de CV
F:4FO
|
MX |
|
I
|
Isabella Bank Corp
NASDAQ:ISBA
|
US |
|
S
|
Sonoma Pharmaceuticals Inc
F:O8Z3
|
US |
|
Airtel Africa PLC
F:9AA0
|
UK |
Wall St Price Targets
9A2 Price Targets Summary
Ares Capital Corp
According to Wall Street analysts, the average 1-year price target for
9A2 is 21.1 EUR with a low forecast of 18.01 EUR and a high forecast of 25.62 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9A2's stock price target?
Price Target
21.1
EUR
According to Wall Street analysts, the average 1-year price target for
9A2 is 21.1 EUR with a low forecast of 18.01 EUR and a high forecast of 25.62 EUR.
What is the Revenue forecast for Ares Capital Corp?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is -2%.
What is the Operating Income forecast for Ares Capital Corp?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Ares Capital Corp?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 2%.